The come-back of hypofractionation?;Hypofractionnement en radiothérapie: Le retour?

Cancer/Radiotherapie

Volumn 9, Issue 6-7, 2005, Pages 366-373

  Cosset, Jean Marc ^a  

^a INSTITUT CURIE   (France)

Author keywords

Fractionation; LQ model; Radiotherapy

Indexed keywords

BREAST CARCINOMA; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; DIAGNOSTIC ACCURACY; HUMAN; MEDICAL SPECIALIST; PRIORITY JOURNAL; PROSTATE CARCINOMA; RADIATION DOSE FRACTIONATION; RADIATION INJURY; RADIOBIOLOGY; REVIEW;

EID: 28344432375     PISSN: 12783218     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canrad.2005.09.013     Document Type: Short Survey

References (45)

1. A.G. Anastasiadis, M.A. Ghafar, L. Salomon, F. Vacherot, P. Benedit, and M.W. Chen Human hormone-refractory prostate cancers can harbor mutations in the O(2)-dependent degradation domain of hypoxia inducible factor-1alpha (HIF-1alpha) J. Cancer Res. Clin. Oncol. 128 2002 358 362
2. H.T. Barkley Jr. Accelerated treatment Cancer 55 1985 2112 2117
3. H. Bartelink, J.C. Horiot, P. Poortmans, H. Struikmans, W. Van den Bogaert, and I. Barillot European Organization for Research and Treatment of Cancer Radiotherapy and Breast Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation N. Engl. J. Med. 345 2001 1378 1387
4. V. Beckendorf, S. Guerif, E. Le Prise, J.M. Cosset, O. Lefloch, and B. Chauvet The GETUG 70 vs 80:Gy randomized trial for localized prostate cancer: feasibility and acute toxicity Int. J. Radiat. Oncol. Biol. Phys. 60 2004 1056 1065
5. D.J. Brenner, and E.J. Hall Fractionation and protraction for radiotherapy of prostate carcinoma Int. J. Radiat. Oncol. Biol. Phys. 43 1999 1095 1101
6. D.J. Brenner, A.A. Martinez, G.K. Edmundson, C. Mitchell, H.D. Thames, and E.P. Armour Direct evidence that prostate tumors show high sensitivity to fractionation (low alpha/beta ratio), similar to late-responding normal tissue Int. J. Radiat. Oncol. Biol. Phys. 52 2002 6 13
7. K. Bujko, M.P. Nowacki, A. Nasierowska-Guttmejer, W. Michalski, M. Bebenek, and M. Pudelko Sphincter preservation following preoperative radiotherapy for rectal cancer: report of a randomised trial comparing short-term radiotherapy vs conventionally fractionated radiochemotherapy Radiother. Oncol. 72 2004 15 24
8. R. Chappell, J. Fowler, and M. Ritter New data on the value of alpha/beta -:evidence mounts that it is low Int. J. Radiat. Oncol. Biol. Phys. 60 2004 1002 1003
9. J.M. Cosset, and F. Baillet Étalement-fractionnement classique, hyperfractionnement, hypofractionnement:: essayons d'̂tre pratiques:! J. Eur. Radiother. 7 1986 73 80
10. J.M. Cosset, M. Henry-Amar, T. Girinski, E. Malaise, N. Dupouy, and J. Dutreix Late toxicity of radiotherapy in Hodgkin's disease. The role of fraction size Acta Oncol. 27 1988 123 129
11. J.M. Cosset, M. Henry-Amar, J.M. Burgers, E.M. Noordijk, B. Van der Werf-Messing, and J.H. Meerwaldt Late radiation injuries of the gastrointestinal tract in the H2 and H5 EORTC Hodgkin's disease trials: emphasis on the role of exploratory laparotomy and fractionation Radiother. Oncol. 13 1988 61 68
12. Cosset JM, Haie-Meder C. La curiethérapie du cancer prostatique: haut ou bas débit de dose? Cancer Radiother. (in press).
13. J.D. Cox Large-dose fractionation (hypofractionation) Cancer 55 1985 2105 2111
14. B.M. Dubray, and H.D. Thames Chronic radiation damage in the rat rectum: an analysis of the influences of fractionation, time and volume Radiother. Oncol. 33 1994 41 47
15. B. Dubray, M. Henry-Amar, J.H. Meerwaldt, E.M. Noordijk, D.O. Dixon, and J.M. Cosset Radiation-induced lung damage after thoracic irradiation for Hodgkin's disease: the role of fractionation Radiother. Oncol. 36 1995 211 217
16. G.M. Duchesne, and L.J. Peters What is the alpha/beta ratio for prostate cancer? Rationale for hypofractionated high-dose-rate brachytherapy Int. J. Radiat. Oncol. Biol. Phys. 44 1999 747 748
17. G.K. Edmundson, F.A. Vicini, P.Y. Chen, C. Mitchell, and A.A. Martinez Dosimetric characteristics of the MammoSite RTS, a new breast brachytherapy applicator Int. J. Radiat. Oncol. Biol. Phys. 52 2002 1132 1139
18. B. Fertil, and E.P. Malaise Intrinsic radiosensitivity of human cell lines is correlated with radioresponsiveness of human tumors: analysis of 101 published survival curves Int. J. Radiat. Oncol. Biol. Phys. 11 1985 1699 1707
19. G.H. Fletcher Hypofractionation: lessons from complications Radiother. Oncol. 20 1991 10 15
20. J. Fowler, R. Chappell, and M. Ritter Is alpha/beta for prostate tumors really low? Int. J. Radiat. Oncol. Biol. Phys. 50 2001 1021 1031
21. J.F. Fowler, R.J. Chappell, and M.A. Ritter The prospects for new treatments for prostate cancer Int. J. Radiat. Oncol. Biol. Phys. 52 2002 3 5
22. J.F. Fowler, M.A. Ritter, R.J. Chappell, and D.J. Brenner What hypofractionated protocols should be tested for prostate cancer? Int. J. Radiat. Oncol. Biol. Phys. 56 2003 1093 1104
23. D. Gallez-Marchal, M. Fayolle, M. Henry-Amar, J.P. Le Bourgeois, P. Rougier, and J.M. Cosset Radiation injuries of the gastrointestinal tract in Hodgkin's disease: the role of exploratory laparotomy and fractionation. A study of 19 cases observed in a series of 134 patients treated at the Institut Gustave-Roussy from 1972 to 1982 Radiother. Oncol. 2 1984 93 99
24. T.E. Goffman, and E. Glatstein Hypofractionation redux? J. Clin. Oncol. 22 2004 589 591
25. B. Jeremic Single fraction external beam radiation therapy in the treatment of localized metastatic bone pain. A review J. Pain Symptom Manage. 22 2001 1048 1058
26. C.R. King, and C.S. Mayo Is the prostate alpha/beta ratio of 1.5 from Brenner and Hall a modeling artifact Int. J. Radiat. Oncol. Biol. Phys. 47 2000 536 539
27. C.R. King, and J.F. Fowler A simple analytic derivation suggests that prostate cancer alpha/beta ratio is low Int. J. Radiat. Oncol. Biol. Phys. 51 2001 213 214
28. A.A. Martinez, I. Pataki, G. Edmundson, E. Sebastian, D. Brabbins, and G. Gustafson Phase II prospective study of the use of conformal high-dose-rate brachytherapy as monotherapy for the treatment of favorable stage prostate cancer: a feasibility report Int. J. Radiat. Oncol. Biol. Phys. 49 2001 61 69
29. A.A. Martinez, G. Gustafson, J. Gonzalez, E. Armour, C. Mitchell, and G. Edmundson Dose escalation using conformal high-dose-rate brachytherapy improves outcome in unfavorable prostate cancer Int. J. Radiat. Oncol. Biol. Phys. 53 2002 316 327
30. A.E. Nahum, B. Movsas, E.M. Horwitz, C.C. Stobbe, and J.D. Chapman Incorporating clinical measurements of hypoxia into tumor local control modeling of prostate cancer: implications for the alpha/beta ratio Int. J. Radiat. Oncol. Biol. Phys. 57 2003 391 401
31. I.A. Olivotto, L.M. Weir, C. Kim-Sing, C.D. Bajdik, C.H. Trevisan, and C.M. Doll Late cosmetic results of short fractionation for breast conservation Radiother. Oncol. 41 1996 7 13
32. C.G. Orton Incorporating clinical measurements of hypoxia into tumor control modeling of prostate cancer: implications for the alpha/beta ratio Int J Radiat Oncol Biol Phys 58 2004 1637 [In regard to Nahum et al. (Int J Radiat Oncol Biol Phys 2003;57:391-401)]
33. A. Pollack, A.L. Hanlon, E.M. Horwitz, S.J. Feigenberg, R.G. Uzzo, and G.E. Hanks Prostate cancer radiotherapy dose response: an update of the fox chase experience J. Urol. 171 2004 1132 1136
34. C.I. Sartor, and J.E. Tepper Is less more? Lessons in radiation schedules in breast cancer J. Natl. Cancer Inst. 94 2002 1114 1115
35. W. Shelley, M. Brundage, C. Hayter, L. Paszat, S. Zhou, and W. Mackillop A shorter fractionation schedule for postlumpectomy breast cancer patients Int. J. Radiat. Oncol. Biol. Phys. 47 2000 1219 1228
36. P. Sminia, C.J. Schneider, and J.F. Fowler The optimal fraction size in high-dose-rate brachytherapy: dependency on tissue repair kinetics and low-dose rate Int. J. Radiat. Oncol. Biol. Phys. 52 2002 844 849
37. H.D. Thames Jr., H.R. Withers, L.J. Peters, and G.H. Fletcher Changes in early and late radiation responses with altered dose fractionation: implications for dose-survival relationships Int. J. Radiat. Oncol. Biol. Phys. 8 1982 219 226
38. H.D. Thames Early fractionation methods and the origins of the NSD concept Acta Oncol. 27 1988 89 103
39. H.D. Thames, and J.H. Hendry Fractionation in radiotherapy 1987 Taylor and Francis London
40. W.B. van den Hout, Y.M. van der Linden, E. Steenland, R.G. Wiggenraad, J. Kievit, and H. de Haes Single- vs multiple-fraction radiotherapy in patients with painful bone metastases: cost-utility analysis based on a randomized trial J. Natl. Cancer Inst. 95 2003 222 229
41. U. Veronesi, R. Orecchia, A. Luini, G. Gatti, M. Intra, and S. Zurrida A preliminary report of intraoperative radiotherapy (IORT) in limited-stage breast cancers that are conservatively treated Eur. J. Cancer 37 2001 2178 2183
42. T. Whelan, R. MacKenzie, J. Julian, M. Levine, W. Shelley, and L. Grimard Randomized trial of breast irradiation schedules after lumpectomy for women with lymph node-negative breast cancer J. Natl. Cancer Inst. 94 2002 1143 1150
43. G. Wiernik, T.D. Bates, R.J. Berry, J. Brindle, J. Bullimore, and J.E. Dalby Seventh interim progress report of the british institute of radiology fractionation study of 3:F/week vs 5:F/week in radiotherapy of the laryngopharynx Br. J. Radiol. 55 1982 505 510
44. J.S. Wu, R. Wong, M. Johnston, A. Bezjak, T. Whelan Cancer Care Ontario Practice Guidelines Initiative Supportive Care Group Meta-analysis of dose-fractionation radiotherapy trials for the palliation of painful bone metastases Int. J. Radiat. Oncol. Biol. Phys. 55 2003 594 605
45. J. Yarnold, A. Ashton, J. Bliss, J. Homewood, C. Harper, and J. Hanson Fractionation sensitivity and dose response of late adverse effects in the breast after radiotherapy for early breast cancer: long-term results of a randomised trial Radiother. Oncol. 75 2005 9 17